Halozyme Therapeutics, Inc.

of this report and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, (the “Exchange Act”) or otherwise

Financial Statements and Exhibits. Exhibit No. Description 99.1 Press release dated January 28, 2026 104 Cover Page Interactive Data File (formatted as inline X